InvestorsHub Logo
Followers 6
Posts 774
Boards Moderated 0
Alias Born 03/07/2014

Re: glg20 post# 66930

Saturday, 02/24/2018 8:09:53 AM

Saturday, February 24, 2018 8:09:53 AM

Post# of 140494
I don’t really care about the day to day swings. I’m looking at the long term play here. The Nasdaq is where the money is at. Make the move and get on with it. Titan is starting to make all the right moves in terms of development, 3 installations, data gathering, surgeon feedback, etc..As someone currently in robotics, I can tell you there is 100% chance this platform will be a strategic play for one of the majors in the medical device business. Very quickly, if you don’t have a robotic platform, you won’t be able to compete for the business, in almost every surgical field, in the US. The rest of the world will eventually catch up. Medtronic, Stryker, JNJ, Smith & Nephew, Braun, Olympus, etc..will all need robotic platforms to compete. Intuitive could continue to acquire technologies in the robotic surgical space, unless the government blocks those acquisitions to avoid a monopolistic market. The fact that this stock hasn’t taken off still shocks me, so undervalued, it’s destined to take off like a rocket ship when Titan is finally discovered. The path for FDA approval for robotic assisted technology continues to become a more beaten path, both the FDA and medical companies developing robotic platforms are working together to align a path for approvals. Unfortunately we have to continue to wait to see a return on our investment, but I believe this investment, especially starting at this PPS, will eventually create a significant ROI for shareholders. McNally will need to continue to push the organization, continue to beat timelines, and be frugal with the finite amount of capital he does have to work with.